Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep 13;2021(9):omab078.
doi: 10.1093/omcr/omab078. eCollection 2021 Sep.

Hepatoid adenocarcinoma of the stomach with PIK3Ca mutation during pregnancy: A case report with molecular profile

Affiliations
Case Reports

Hepatoid adenocarcinoma of the stomach with PIK3Ca mutation during pregnancy: A case report with molecular profile

Anastasija Ranceva et al. Oxf Med Case Reports. .

Abstract

Hepatoid adenocarcinoma is an extremely aggressive special subtype of gastric tumors. It can be lethal as no standard treatment options for this type of gastric cancer exist. Here, we describe a very rare case of a young female on her 21st week of pregnancy who was diagnosed with stage IV hepatoid adenocarcinoma of the stomach with elevated α fetoprotein (AFP) level. Gene mutation analysis performed by next-generation sequencing identified somatic mutations in the PIK3CA gene. Despite the treatment, patient died 2 months after the initial disease presentation. To our best knowledge, this case represents the first report of pregnancy-associated hepatoid gastric adenocarcinoma with the PIK3CA gene mutations, which can provide further clues for the understanding of molecular features of this type of tumor that can reflect biological behavior and may lead to further effective treatment options.

Keywords: PIK3CA, NGS; gastric cancer; hepatoid adenocarcinoma; pregnancy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Magnetic resonance imaging: A) thickening of the gastric wall, B) perigastric lymph node enlargement and C) pleural effusion (red arrows).
Figure 2
Figure 2
Esophagogastroduodenoscopy imaging: an infiltrative ulcerated tumor of the stomach 4 cm in size (white arrows).
Figure 3
Figure 3
Biopsy (hematoxylin & eosin, 10× magnification): focal gland formation (blue arrows).
Figure 4
Figure 4
Biopsy (hematoxylin & eosin, 15× magnification): solid sheets of large polygonal cells with focal nuclear pleomorphism (blue arrow) and mitoses (green arrow).
Figure 5
Figure 5
Biopsy (Hep-Par-1 immunohistochemistry, 10× magnification): focal positive cytoplasmic reaction (red arrows).
Figure 6
Figure 6
Biopsy (Alpha-fetoprotein (AFP) immunohistochemistry, 10× magnification): focal positive cytoplasmic reaction (red arrows).

References

    1. Niknam R, Haghighat S, Mokhtari M. The pregnancy-associated gastric cancer: a case report and review of the literature. J Obstet Gynaecol. 2020;20:1–2. - PubMed
    1. Pacheco S, Norero E. The Rare and Challenging Presentation of Gastric Cancer during Pregnancy: A Report of Three Cases. J Gastric Cancer. 2016;16:271–6. - PMC - PubMed
    1. Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy. Acta Obstet Gynecol Scand. 2020;99:79–88. 10.1111/aogs.13731. - DOI - PMC - PubMed
    1. Wang Y, Sun L, Li Z. Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features. Gastric Cancer. 2019;22. - PMC - PubMed
    1. Su JS, Chen YT. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol. 2013;19:321–7. - PMC - PubMed

Publication types